{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:40:42Z","timestamp":1780638042988,"version":"3.54.1"},"publisher-location":"Cham","reference-count":268,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030590376","type":"print"},{"value":"9783030590383","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-3-030-59038-3_4","type":"book-chapter","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T15:06:56Z","timestamp":1624979216000},"page":"49-78","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Microenvironment of Tongue Cancer"],"prefix":"10.1007","author":[{"given":"Want","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeng","family":"Li-Juan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jing-Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Xiang-Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Yu-Jie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,30]]},"reference":[{"issue":"1","key":"4_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66(1):7\u201330","journal-title":"CA Cancer J Clin"},{"key":"4_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1758-3284-3-27","volume":"3","author":"H Kokemueller","year":"2011","unstructured":"Kokemueller H, Rana M, Rublack J, Eckardt A, Tavassol F, Schumann P et al (2011) The Hannover experience: surgical treatment of tongue cancer \u2013 a clinical retrospective evaluation over a 30 years\u2019 period. Head Neck Oncol 3:27","journal-title":"Head Neck Oncol"},{"issue":"4","key":"4_CR3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00281-011-0264-x","volume":"33","author":"G Bindea","year":"2011","unstructured":"Bindea G et al (2011) The prognostic impact of anti-cancer immune response: a novel classification of cancer patients. Semin Immunopathol 33(4):335\u2013340","journal-title":"Semin Immunopathol"},{"issue":"8","key":"4_CR4","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3109\/00016489.2014.918279","volume":"134","author":"H Hanakawa","year":"2014","unstructured":"Hanakawa H et al (2014) Regulatory T-cell infiltration in tongue squamous cell carcinoma. Acta Otolaryngol 134(8):859\u2013864","journal-title":"Acta Otolaryngol"},{"issue":"11","key":"4_CR5","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s00262-016-1902-x","volume":"65","author":"K Miki","year":"2016","unstructured":"Miki K et al (2016) Regulatory T cells function at the early stage of tumor progression in a mouse model of tongue squamous cell carcinoma. Cancer Immunol Immunother 65(11):1401\u20131410","journal-title":"Cancer Immunol Immunother"},{"issue":"7","key":"4_CR6","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1007\/s00784-013-1146-5","volume":"18","author":"J Zhao","year":"2014","unstructured":"Zhao J et al (2014) Increased frequency of CD4+ CD25+ FOXP3+ cells correlates with the progression of 4-nitroquinoline1-oxide-induced rat tongue carcinogenesis. Clin Oral Investig 18(7):1725\u20131730","journal-title":"Clin Oral Investig"},{"issue":"1","key":"4_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13014-018-1099-6","volume":"13","author":"WY Chen","year":"2018","unstructured":"Chen WY et al (2018) Prognostic significance of tumor-infiltrating lymphocytes in patients with operable tongue cancer. Radiat Oncol 13(1):157","journal-title":"Radiat Oncol"},{"issue":"1","key":"4_CR8","doi-asserted-by":"publisher","first-page":"246","DOI":"10.4049\/jimmunol.177.1.246","volume":"177","author":"M Mahic","year":"2006","unstructured":"Mahic M et al (2006) FOXP3+CD4+CD25+ adaptive regulatory T cells express cyclooxygenase-2 and suppress effector T cells by a prostaglandin E2-dependent mechanism. J Immunol 177(1):246\u2013254","journal-title":"J Immunol"},{"issue":"10","key":"4_CR9","doi-asserted-by":"publisher","first-page":"4779","DOI":"10.4049\/jimmunol.1402051","volume":"193","author":"Q Zhu","year":"2014","unstructured":"Zhu Q et al (2014) Cutting edge: STING mediates protection against colorectal tumorigenesis by governing the magnitude of intestinal inflammation. J Immunol 193(10):4779\u20134782","journal-title":"J Immunol"},{"issue":"11","key":"4_CR10","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1016\/j.bbadis.2015.08.011","volume":"1852","author":"D Liang","year":"2015","unstructured":"Liang D et al (2015) Activated STING enhances Tregs infiltration in the HPV-related carcinogenesis of tongue squamous cells via the c-jun\/CCL22 signal. Biochim Biophys Acta 1852(11):2494\u20132503","journal-title":"Biochim Biophys Acta"},{"issue":"22","key":"4_CR11","doi-asserted-by":"publisher","first-page":"6365","DOI":"10.1158\/0008-5472.CAN-16-3453","volume":"77","author":"AK Mattox","year":"2017","unstructured":"Mattox AK et al (2017) PD-1 expression in head and neck squamous cell carcinomas derives primarily from functionally anergic CD4(+) TILs in the presence of PD-L1(+) TAMs. Cancer Res 77(22):6365\u20136374","journal-title":"Cancer Res"},{"key":"4_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ctro.2019.05.001","volume":"17","author":"SL Lee","year":"2019","unstructured":"Lee SL et al (2019) Computer-assisted image analysis of the tumor microenvironment on an oral tongue squamous cell carcinoma tissue microarray. Clin Transl Radiat Oncol 17:32\u201339","journal-title":"Clin Transl Radiat Oncol"},{"issue":"1","key":"4_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.21873\/anticanres.13126","volume":"39","author":"K Furukawa","year":"2019","unstructured":"Furukawa K et al (2019) Prognostic significance of pretreatment lymphocyte-to-monocyte ratio in patients with tongue cancer. Anticancer Res 39(1):405\u2013412","journal-title":"Anticancer Res"},{"issue":"11","key":"4_CR14","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1016\/j.ejca.2013.03.019","volume":"49","author":"C Nordfors","year":"2013","unstructured":"Nordfors C et al (2013) CD8+ and CD4+ tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma. Eur J Cancer 49(11):2522\u20132530","journal-title":"Eur J Cancer"},{"issue":"12","key":"4_CR15","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1007\/s00262-017-2054-3","volume":"66","author":"L Jouhi","year":"2017","unstructured":"Jouhi L et al (2017) Toll-like receptor 5 and 7 expression may impact prognosis of HPV-positive oropharyngeal squamous cell carcinoma patients. Cancer Immunol Immunother 66(12):1619\u20131629","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"4_CR16","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1080\/00016489.2018.1552014","volume":"139","author":"L Haeggblom","year":"2019","unstructured":"Haeggblom L et al (2019) TLR5 and TLR7 are differentially expressed in human papillomavirus-positive and negative base of tongue squamous cell carcinoma, and TLR7 may have an independent prognostic influence. Acta Otolaryngol 139(2):206\u2013210","journal-title":"Acta Otolaryngol"},{"key":"4_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-7-40","volume":"7","author":"C Jiang","year":"2007","unstructured":"Jiang C et al (2007) Response of lymphocyte subsets and cytokines to Shenyang prescription in Sprague-Dawley rats with tongue squamous cell carcinomas induced by 4NQO. BMC Cancer 7:40","journal-title":"BMC Cancer"},{"issue":"6","key":"4_CR18","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3390\/cancers9060062","volume":"9","author":"CA Levingston","year":"2017","unstructured":"Levingston CA, Young MRI (2017) Local immune responsiveness of mice bearing premalignant oral lesions to PD-1 antibody treatment. Cancers (Basel) 9(6):62","journal-title":"Cancers (Basel)"},{"key":"4_CR19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.archoralbio.2018.04.015","volume":"92","author":"F Liao","year":"2018","unstructured":"Liao F et al (2018) Curcumin enhances anti-tumor immune response in tongue squamous cell carcinoma. Arch Oral Biol 92:32\u201337","journal-title":"Arch Oral Biol"},{"issue":"9","key":"4_CR20","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1038\/sj.bjc.6600282","volume":"86","author":"G Gannot","year":"2002","unstructured":"Gannot G et al (2002) Increase in immune cell infiltration with progression of oral epithelium from hyperkeratosis to dysplasia and carcinoma. Br J Cancer 86(9):1444\u20131448","journal-title":"Br J Cancer"},{"issue":"4","key":"4_CR21","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/cjp2.138","volume":"5","author":"X Gu","year":"2019","unstructured":"Gu X et al (2019) High immune cytolytic activity in tumor-free tongue tissue confers better prognosis in patients with squamous cell carcinoma of the oral tongue. J Pathol Clin Res 5(4):240\u2013247","journal-title":"J Pathol Clin Res"},{"issue":"2","key":"4_CR22","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.2353\/ajpath.2010.090757","volume":"176","author":"G Krikun","year":"2010","unstructured":"Krikun G et al (2010) The immunoconjugate \u201cicon\u201d targets aberrantly expressed endothelial tissue factor causing regression of endometriosis. Am J Pathol 176(2):1050\u20131056","journal-title":"Am J Pathol"},{"issue":"6","key":"4_CR23","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/sj.bjc.6605760","volume":"103","author":"E Cocco","year":"2010","unstructured":"Cocco E et al (2010) hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary carcinoma. Br J Cancer 103(6):812\u2013819","journal-title":"Br J Cancer"},{"key":"4_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2172-11-49","volume":"11","author":"Z Hu","year":"2010","unstructured":"Hu Z, Li J (2010) Natural killer cells are crucial for the efficacy of Icon (factor VII\/human IgG1 Fc) immunotherapy in human tongue cancer. BMC Immunol 11:49","journal-title":"BMC Immunol"},{"issue":"12","key":"4_CR25","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1002\/cncr.11843","volume":"98","author":"JL Ambrus Sr","year":"2003","unstructured":"Ambrus JL Sr et al (2003) Free interferon-alpha\/beta receptors in the circulation of patients with adenocarcinoma. Cancer 98(12):2730\u20132733","journal-title":"Cancer"},{"issue":"1","key":"4_CR26","first-page":"54","volume":"136","author":"KK Mukherjee","year":"2012","unstructured":"Mukherjee KK et al (2012) IFNalpha2b augments immune responses of cisplatin+5-fluorouracil treated tongue squamous cell carcinoma patients \u2013 a preliminary study. Indian J Med Res 136(1):54\u201359","journal-title":"Indian J Med Res"},{"issue":"6","key":"4_CR27","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1001\/archotol.124.6.641","volume":"124","author":"SA Goldman","year":"1998","unstructured":"Goldman SA et al (1998) Peritumoral CD1a-positive dendritic cells are associated with improved survival in patients with tongue carcinoma. Arch Otolaryngol Head Neck Surg 124(6):641\u2013646","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"12","key":"4_CR28","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.prp.2016.09.011","volume":"212","author":"O Hilly","year":"2016","unstructured":"Hilly O et al (2016) The predictive value of dendritic cells in early squamous cell carcinoma of the tongue. Pathol Res Pract 212(12):1138\u20131143","journal-title":"Pathol Res Pract"},{"issue":"6","key":"4_CR29","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/his.13415","volume":"72","author":"JF Jardim","year":"2018","unstructured":"Jardim JF et al (2018) A decreased peritumoral CD1a+ cell number predicts a worse prognosis in oral squamous cell carcinoma. Histopathology 72(6):905\u2013913","journal-title":"Histopathology"},{"issue":"6","key":"4_CR30","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.ijom.2005.11.004","volume":"35","author":"Z Wang","year":"2006","unstructured":"Wang Z et al (2006) Effect of dendritic cell vaccine against a tongue squamous cell cancer cell line (Tca8113) in vivo and in vitro. Int J Oral Maxillofac Surg 35(6):544\u2013550","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"2","key":"4_CR31","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/CJI.0b013e31815bdbf5","volume":"31","author":"MR Young","year":"2008","unstructured":"Young MR (2008) Use of carcinogen-induced premalignant oral lesions in a dendritic cell-based vaccine to stimulate immune reactivity against both premalignant oral lesions and oral cancer. J Immunother 31(2):148\u2013156","journal-title":"J Immunother"},{"issue":"3","key":"4_CR32","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.intimp.2012.05.004","volume":"13","author":"AM De Costa","year":"2012","unstructured":"De Costa AM et al (2012) Administration of a vaccine composed of dendritic cells pulsed with premalignant oral lesion lysate to mice bearing carcinogen-induced premalignant oral lesions stimulates a protective immune response. Int Immunopharmacol 13(3):322\u2013330","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"4_CR33","first-page":"81","volume":"41","author":"W Han","year":"2006","unstructured":"Han W, Hu QG, Wang ZY (2006) Inhibitory effect of dendritic cell vaccine on the growth of implanted tongue squamous cell carcinoma tumors in nude mice. Zhonghua Kou Qiang Yi Xue Za Zhi 41(2):81\u201384","journal-title":"Zhonghua Kou Qiang Yi Xue Za Zhi"},{"issue":"22","key":"4_CR34","doi-asserted-by":"publisher","first-page":"8262","DOI":"10.1158\/0008-5472.CAN-04-2056","volume":"64","author":"TD Shellenberger","year":"2004","unstructured":"Shellenberger TD et al (2004) BRAK\/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells. Cancer Res 64(22):8262\u20138270","journal-title":"Cancer Res"},{"key":"4_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.oraloncology.2015.11.003","volume":"53","author":"X Zhou","year":"2016","unstructured":"Zhou X et al (2016) CD19(+)IL-10(+) regulatory B cells affect survival of tongue squamous cell carcinoma patients and induce resting CD4(+) T cells to CD4(+)Foxp3(+) regulatory T cells. Oral Oncol 53:27\u201335","journal-title":"Oral Oncol"},{"issue":"1","key":"4_CR36","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1601-0825.2011.01846.x","volume":"18","author":"M Chu","year":"2012","unstructured":"Chu M et al (2012) Myeloid-derived suppressor cells contribute to oral cancer progression in 4NQO-treated mice. Oral Dis 18(1):67\u201373","journal-title":"Oral Dis"},{"issue":"10","key":"4_CR37","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1226719","volume":"5","author":"CW Fugle","year":"2016","unstructured":"Fugle CW et al (2016) CD24 blunts oral squamous cancer development and dampens the functional expansion of myeloid-derived suppressor cells. Oncoimmunology 5(10):e1226719","journal-title":"Oncoimmunology"},{"issue":"1","key":"4_CR38","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/hed.21138","volume":"32","author":"CF Lu","year":"2010","unstructured":"Lu CF et al (2010) Infiltrating macrophage count: a significant predictor for the progression and prognosis of oral squamous cell carcinomas in Taiwan. Head Neck 32(1):18\u201325","journal-title":"Head Neck"},{"issue":"3","key":"4_CR39","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1590\/0103-6440201302049","volume":"24","author":"DS Boas","year":"2013","unstructured":"Boas DS et al (2013) Tumor-infiltrating macrophage and microvessel density in oral squamous cell carcinoma. Braz Dent J 24(3):194\u2013199","journal-title":"Braz Dent J"},{"issue":"3","key":"4_CR40","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/ijc.28066","volume":"133","author":"Y Usami","year":"2013","unstructured":"Usami Y et al (2013) Intercellular adhesion molecule-1 (ICAM-1) expression correlates with oral cancer progression and induces macrophage\/cancer cell adhesion. Int J Cancer 133(3):568\u2013578","journal-title":"Int J Cancer"},{"issue":"3","key":"4_CR41","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000477301","volume":"93","author":"K Miki","year":"2017","unstructured":"Miki K et al (2017) Tumor-associated macrophages in the development of 4-nitroquinoline-1-oxide-induced tongue squamous cell carcinoma in a mouse model. Oncology 93(3):204\u2013212","journal-title":"Oncology"},{"issue":"3","key":"4_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120895","volume":"10","author":"E Pirila","year":"2015","unstructured":"Pirila E et al (2015) Macrophages modulate migration and invasion of human tongue squamous cell carcinoma. PLoS One 10(3):e0120895","journal-title":"PLoS One"},{"issue":"10","key":"4_CR43","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1016\/j.joms.2017.03.009","volume":"75","author":"Y Yamagata","year":"2017","unstructured":"Yamagata Y et al (2017) CD163-positive macrophages within the tumor stroma are associated with lymphangiogenesis and lymph node metastasis in Oral squamous cell carcinoma. J Oral Maxillofac Surg 75(10):2144\u20132153","journal-title":"J Oral Maxillofac Surg"},{"issue":"12","key":"4_CR44","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1002\/ijc.27966","volume":"132","author":"T Tsujikawa","year":"2013","unstructured":"Tsujikawa T et al (2013) Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4\/CCL22 in head and neck squamous cell carcinoma. Int J Cancer 132(12):2755\u20132766","journal-title":"Int J Cancer"},{"issue":"6","key":"4_CR45","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.3892\/or.2012.2019","volume":"28","author":"L Bian","year":"2012","unstructured":"Bian L et al (2012) Oral cancer-associated fibroblasts inhibit heat-induced apoptosis in Tca8113 cells through upregulated expression of Bcl-2 through the Mig\/CXCR3 axis. Oncol Rep 28(6):2063\u20132068","journal-title":"Oncol Rep"},{"issue":"3","key":"4_CR46","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000218708","volume":"30","author":"F Angeli","year":"2009","unstructured":"Angeli F et al (2009) Role of stromal fibroblasts in cancer: promoting or impeding? Tumour Biol 30(3):109\u2013120","journal-title":"Tumour Biol"},{"issue":"1","key":"4_CR47","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.gde.2009.01.003","volume":"19","author":"A Ostman","year":"2009","unstructured":"Ostman A, Augsten M (2009) Cancer-associated fibroblasts and tumor growth \u2013 bystanders turning into key players. Curr Opin Genet Dev 19(1):67\u201373","journal-title":"Curr Opin Genet Dev"},{"key":"4_CR48","doi-asserted-by":"publisher","first-page":"166","DOI":"10.2741\/3613","volume":"15","author":"F Xing","year":"2010","unstructured":"Xing F, Saidou J, Watabe K (2010) Cancer associated fibroblasts (CAFs) in tumor microenvironment. Front Biosci 15:166\u2013179","journal-title":"Front Biosci"},{"issue":"6","key":"4_CR49","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1002\/ijc.25358","volume":"127","author":"M Vered","year":"2010","unstructured":"Vered M et al (2010) Cancer-associated fibroblasts and epithelial-mesenchymal transition in metastatic oral tongue squamous cell carcinoma. Int J Cancer 127(6):1356\u20131362","journal-title":"Int J Cancer"},{"issue":"1","key":"4_CR50","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.oraloncology.2010.10.013","volume":"47","author":"IO Bello","year":"2011","unstructured":"Bello IO et al (2011) Cancer-associated fibroblasts, a parameter of the tumor microenvironment, overcomes carcinoma-associated parameters in the prognosis of patients with mobile tongue cancer. Oral Oncol 47(1):33\u201338","journal-title":"Oral Oncol"},{"issue":"3","key":"4_CR51","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1158\/0008-5472.CAN-07-5714","volume":"68","author":"RF Hwang","year":"2008","unstructured":"Hwang RF et al (2008) Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res 68(3):918\u2013926","journal-title":"Cancer Res"},{"issue":"4","key":"4_CR52","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1158\/0008-5472.CAN-03-1860","volume":"64","author":"S Muerkoster","year":"2004","unstructured":"Muerkoster S et al (2004) Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and interleukin-1beta. Cancer Res 64(4):1331\u20131337","journal-title":"Cancer Res"},{"issue":"5","key":"4_CR53","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.2353\/ajpath.2007.061004","volume":"170","author":"MP Shekhar","year":"2007","unstructured":"Shekhar MP et al (2007) Direct involvement of breast tumor fibroblasts in the modulation of tamoxifen sensitivity. Am J Pathol 170(5):1546\u20131560","journal-title":"Am J Pathol"},{"key":"4_CR54","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.biopha.2017.11.024","volume":"97","author":"JK Liao","year":"2018","unstructured":"Liao JK et al (2018) Cancer-associated fibroblasts confer cisplatin resistance of tongue cancer via autophagy activation. Biomed Pharmacother 97:1341\u20131348","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"4_CR55","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1158\/0008-5472.CAN-15-1625","volume":"76","author":"L Li","year":"2016","unstructured":"Li L et al (2016) Exosomes derived from hypoxic oral squamous cell carcinoma cells deliver miR-21 to normoxic cells to elicit a prometastatic phenotype. Cancer Res 76(7):1770\u20131780","journal-title":"Cancer Res"},{"key":"4_CR56","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.oraloncology.2018.09.030","volume":"86","author":"T Fujiwara","year":"2018","unstructured":"Fujiwara T et al (2018) Carcinogenic epithelial-mesenchymal transition initiated by oral cancer exosomes is inhibited by anti-EGFR antibody cetuximab. Oral Oncol 86:251\u2013257","journal-title":"Oral Oncol"},{"issue":"1","key":"4_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0985-3","volume":"18","author":"C Xie","year":"2019","unstructured":"Xie C et al (2019) The role of extracellular vesicles from different origin in the microenvironment of head and neck cancers. Mol Cancer 18(1):83","journal-title":"Mol Cancer"},{"issue":"6","key":"4_CR58","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/hed.23684","volume":"37","author":"T Tanvetyanon","year":"2015","unstructured":"Tanvetyanon T et al (2015) Postoperative concurrent chemotherapy and radiotherapy for high-risk cutaneous squamous cell carcinoma of the head and neck. Head Neck 37(6):840\u2013845","journal-title":"Head Neck"},{"issue":"9","key":"4_CR59","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1093\/abbs\/gmx078","volume":"49","author":"T Liu","year":"2017","unstructured":"Liu T et al (2017) Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma. Acta Biochim Biophys Sin Shanghai 49(9):808\u2013816","journal-title":"Acta Biochim Biophys Sin Shanghai"},{"issue":"2","key":"4_CR60","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/mc.22744","volume":"57","author":"T Kawakubo-Yasukochi","year":"2018","unstructured":"Kawakubo-Yasukochi T et al (2018) miR-200c-3p spreads invasive capacity in human oral squamous cell carcinoma microenvironment. Mol Carcinog 57(2):295\u2013302","journal-title":"Mol Carcinog"},{"key":"4_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/srep38750","volume":"6","author":"S Sakha","year":"2016","unstructured":"Sakha S et al (2016) Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma. Sci Rep 6:38750","journal-title":"Sci Rep"},{"issue":"2","key":"4_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148454","volume":"11","author":"S Sento","year":"2016","unstructured":"Sento S, Sasabe E, Yamamoto T (2016) Application of a persistent heparin treatment inhibits the malignant potential of oral squamous carcinoma cells induced by tumor cell-derived exosomes. PLoS One 11(2):e0148454","journal-title":"PLoS One"},{"issue":"1","key":"4_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0994-2","volume":"18","author":"ME Fiori","year":"2019","unstructured":"Fiori ME et al (2019) Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance. Mol Cancer 18(1):70","journal-title":"Mol Cancer"},{"issue":"5","key":"4_CR64","first-page":"2432","volume":"8","author":"LR Languino","year":"2016","unstructured":"Languino LR et al (2016) Exosome-mediated transfer from the tumor microenvironment increases TGFbeta signaling in squamous cell carcinoma. Am J Transl Res 8(5):2432\u20132437","journal-title":"Am J Transl Res"},{"key":"4_CR65","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ebiom.2018.09.006","volume":"36","author":"YY Li","year":"2018","unstructured":"Li YY et al (2018) Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p. EBioMedicine 36:209\u2013220","journal-title":"EBioMedicine"},{"issue":"1","key":"4_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1144-9","volume":"38","author":"X Wang","year":"2019","unstructured":"Wang X et al (2019) Loss of exosomal miR-3188 in cancer-associated fibroblasts contributes to HNC progression. J Exp Clin Cancer Res 38(1):151","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"4_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-018-1604-0","volume":"20","author":"X Qin","year":"2019","unstructured":"Qin X et al (2019) Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5. Genome Biol 20(1):12","journal-title":"Genome Biol"},{"issue":"1","key":"4_CR68","doi-asserted-by":"publisher","first-page":"1578525","DOI":"10.1080\/20013078.2019.1578525","volume":"8","author":"MR Dourado","year":"2019","unstructured":"Dourado MR et al (2019) Extracellular vesicles derived from cancer-associated fibroblasts induce the migration and invasion of oral squamous cell carcinoma. J Extracell Vesicles 8(1):1578525","journal-title":"J Extracell Vesicles"},{"key":"4_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1030-6","volume":"15","author":"M Vered","year":"2015","unstructured":"Vered M et al (2015) Caveolin-1 accumulation in the tongue cancer tumor microenvironment is significantly associated with poor prognosis: an in-vivo and in-vitro study. BMC Cancer 15:25","journal-title":"BMC Cancer"},{"issue":"8","key":"4_CR70","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1096\/fj.201601138RR","volume":"31","author":"AM Overmiller","year":"2017","unstructured":"Overmiller AM et al (2017) Desmoglein 2 modulates extracellular vesicle release from squamous cell carcinoma keratinocytes. FASEB J 31(8):3412\u20133424","journal-title":"FASEB J"},{"issue":"5","key":"4_CR71","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646\u2013674","journal-title":"Cell"},{"issue":"11","key":"4_CR72","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1158\/1541-7786.MCR-18-0358","volume":"16","author":"N Ludwig","year":"2018","unstructured":"Ludwig N et al (2018) Exosomes from HNSCC promote angiogenesis through reprogramming of endothelial cells. Mol Cancer Res 16(11):1798\u20131808","journal-title":"Mol Cancer Res"},{"issue":"10","key":"4_CR73","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1080\/15384047.2017.1373213","volume":"18","author":"X Huaitong","year":"2017","unstructured":"Huaitong X et al (2017) Microvesicles releasing by oral cancer cells enhance endothelial cell angiogenesis via Shh\/RhoA signaling pathway. Cancer Biol Ther 18(10):783\u2013791","journal-title":"Cancer Biol Ther"},{"issue":"8","key":"4_CR74","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1177\/0022034516641037","volume":"95","author":"JG Ren","year":"2016","unstructured":"Ren JG et al (2016) Clinical significance and roles in angiogenesis of circulating microparticles in oral cancer. J Dent Res 95(8):860\u2013867","journal-title":"J Dent Res"},{"issue":"5","key":"4_CR75","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/odi.12765","volume":"24","author":"A de Andrade","year":"2018","unstructured":"de Andrade A et al (2018) Extracellular vesicles from oral squamous carcinoma cells display pro- and anti-angiogenic properties. Oral Dis 24(5):725\u2013731","journal-title":"Oral Dis"},{"issue":"1","key":"4_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-36855-6","volume":"9","author":"L Rosenberger","year":"2019","unstructured":"Rosenberger L et al (2019) Stem cell exosomes inhibit angiogenesis and tumor growth of oral squamous cell carcinoma. Sci Rep 9(1):663","journal-title":"Sci Rep"},{"issue":"3","key":"4_CR77","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1096\/fj.201600984R","volume":"31","author":"S Katsiougiannis","year":"2017","unstructured":"Katsiougiannis S et al (2017) Saliva exosomes from pancreatic tumor-bearing mice modulate NK cell phenotype and antitumor cytotoxicity. FASEB J 31(3):998\u20131010","journal-title":"FASEB J"},{"key":"4_CR78","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.oraloncology.2017.11.024","volume":"76","author":"Y Wang","year":"2018","unstructured":"Wang Y et al (2018) Oral cancer-derived exosomal NAP1 enhances cytotoxicity of natural killer cells via the IRF-3 pathway. Oral Oncol 76:34\u201341","journal-title":"Oral Oncol"},{"issue":"4","key":"4_CR79","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1158\/1078-0432.CCR-17-2664","volume":"24","author":"MN Theodoraki","year":"2018","unstructured":"Theodoraki MN et al (2018) Clinical significance of PD-L1(+) exosomes in plasma of head and neck cancer patients. Clin Cancer Res 24(4):896\u2013905","journal-title":"Clin Cancer Res"},{"issue":"7718","key":"4_CR80","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","volume":"560","author":"G Chen","year":"2018","unstructured":"Chen G et al (2018) Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature 560(7718):382\u2013386","journal-title":"Nature"},{"issue":"15","key":"4_CR81","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1038\/s41388-018-0627-z","volume":"38","author":"L Li","year":"2019","unstructured":"Li L et al (2019) Microenvironmental oxygen pressure orchestrates an anti- and pro-tumoral gammadelta T cell equilibrium via tumor-derived exosomes. Oncogene 38(15):2830\u20132843","journal-title":"Oncogene"},{"issue":"78","key":"4_CR82","doi-asserted-by":"publisher","first-page":"34838","DOI":"10.18632\/oncotarget.26208","volume":"9","author":"F Momen-Heravi","year":"2018","unstructured":"Momen-Heravi F, Bala S (2018) Extracellular vesicles in oral squamous carcinoma carry oncogenic miRNA profile and reprogram monocytes via NF-kappaB pathway. Oncotarget 9(78):34838\u201334854","journal-title":"Oncotarget"},{"issue":"1","key":"4_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-018-0815-2","volume":"37","author":"M Xiao","year":"2018","unstructured":"Xiao M et al (2018) M1-like tumor-associated macrophages activated by exosome-transferred THBS1 promote malignant migration in oral squamous cell carcinoma. J Exp Clin Cancer Res 37(1):143","journal-title":"J Exp Clin Cancer Res"},{"issue":"16","key":"4_CR84","doi-asserted-by":"publisher","first-page":"4843","DOI":"10.1158\/1078-0432.CCR-16-2819","volume":"23","author":"S Ludwig","year":"2017","unstructured":"Ludwig S et al (2017) Suppression of lymphocyte functions by plasma exosomes correlates with disease activity in patients with head and neck cancer. Clin Cancer Res 23(16):4843\u20134854","journal-title":"Clin Cancer Res"},{"issue":"1","key":"4_CR85","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1021\/acsnano.6b05630","volume":"11","author":"W Zhang","year":"2017","unstructured":"Zhang W et al (2017) Magnetic and folate functionalization enables rapid isolation and enhanced tumor-targeting of cell-derived microvesicles. ACS Nano 11(1):277\u2013290","journal-title":"ACS Nano"},{"key":"4_CR86","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.omtn.2018.11.009","volume":"14","author":"L Li","year":"2019","unstructured":"Li L et al (2019) GammadeltaTDEs: an efficient delivery system for miR-138 with anti-tumoral and immunostimulatory roles on oral squamous cell carcinoma. Mol Ther Nucleic Acids 14:101\u2013113","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"4_CR87","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1080\/21691401.2019.1623232","volume":"47","author":"L Wang","year":"2019","unstructured":"Wang L et al (2019) Delivery of mesenchymal stem cells-derived extracellular vesicles with enriched miR-185 inhibits progression of OPMD. Artif Cells Nanomed Biotechnol 47(1):2481\u20132491","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"1","key":"4_CR88","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12943-019-0986-2","volume":"18","author":"H Bai","year":"2019","unstructured":"Bai H et al (2019) Exo-circRNAs: a new paradigm for anticancer therapy. Mol Cancer 18(1):56","journal-title":"Mol Cancer"},{"key":"4_CR89","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.oraloncology.2017.09.012","volume":"74","author":"P Economopoulou","year":"2017","unstructured":"Economopoulou P et al (2017) Liquid biopsy: an emerging prognostic and predictive tool in head and neck squamous cell carcinoma (HNSCC). Focus on circulating tumor cells (CTCs). Oral Oncol 74:83\u201389","journal-title":"Oral Oncol"},{"key":"4_CR90","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.semcdb.2017.12.011","volume":"78","author":"K Kai","year":"2018","unstructured":"Kai K, Dittmar RL, Sen S (2018) Secretory microRNAs as biomarkers of cancer. Semin Cell Dev Biol 78:22\u201336","journal-title":"Semin Cell Dev Biol"},{"key":"4_CR91","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.oraloncology.2018.07.001","volume":"84","author":"S Nair","year":"2018","unstructured":"Nair S et al (2018) Salivary exosomes as potential biomarkers in cancer. Oral Oncol 84:31\u201340","journal-title":"Oral Oncol"},{"key":"4_CR92","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.cellsig.2017.10.009","volume":"42","author":"F Momen-Heravi","year":"2018","unstructured":"Momen-Heravi F, Bala S (2018) Emerging role of non-coding RNA in oral cancer. Cell Signal 42:134\u2013143","journal-title":"Cell Signal"},{"issue":"1","key":"4_CR93","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00432-015-2005-3","volume":"142","author":"A Zlotogorski-Hurvitz","year":"2016","unstructured":"Zlotogorski-Hurvitz A et al (2016) Morphological and molecular features of oral fluid-derived exosomes: oral cancer patients versus healthy individuals. J Cancer Res Clin Oncol 142(1):101\u2013110","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"4_CR94","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00432-018-02827-6","volume":"145","author":"A Zlotogorski-Hurvitz","year":"2019","unstructured":"Zlotogorski-Hurvitz A et al (2019) FTIR-based spectrum of salivary exosomes coupled with computational-aided discriminating analysis in the diagnosis of oral cancer. J Cancer Res Clin Oncol 145(3):685\u2013694","journal-title":"J Cancer Res Clin Oncol"},{"key":"4_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/srep16305","volume":"5","author":"FV Winck","year":"2015","unstructured":"Winck FV et al (2015) Insights into immune responses in oral cancer through proteomic analysis of saliva and salivary extracellular vesicles. Sci Rep 5:16305","journal-title":"Sci Rep"},{"issue":"9","key":"4_CR96","doi-asserted-by":"publisher","first-page":"7350","DOI":"10.1002\/jcb.27039","volume":"119","author":"K Ono","year":"2018","unstructured":"Ono K et al (2018) HSP-enriched properties of extracellular vesicles involve survival of metastatic oral cancer cells. J Cell Biochem 119(9):7350\u20137362","journal-title":"J Cell Biochem"},{"issue":"1","key":"4_CR97","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2018.1440131","volume":"7","author":"Y Yang","year":"2018","unstructured":"Yang Y et al (2018) Extracellular vesicles as a platform for membrane-associated therapeutic protein delivery. J Extracell Vesicles 7(1):1440131","journal-title":"J Extracell Vesicles"},{"issue":"14","key":"4_CR98","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1088\/0031-9155\/48\/14\/310","volume":"48","author":"A Samani","year":"2003","unstructured":"Samani A et al (2003) Measuring the elastic modulus of ex vivo small tissue samples. Phys Med Biol 48(14):2183\u20132198","journal-title":"Phys Med Biol"},{"issue":"6","key":"4_CR99","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1088\/0031-9155\/52\/6\/002","volume":"52","author":"A Samani","year":"2007","unstructured":"Samani A, Zubovits J, Plewes D (2007) Elastic moduli of normal and pathological human breast tissues: an inversion-technique-based investigation of 169 samples. Phys Med Biol 52(6):1565\u20131576","journal-title":"Phys Med Biol"},{"issue":"10","key":"4_CR100","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1039\/c5ib00040h","volume":"7","author":"I Acerbi","year":"2015","unstructured":"Acerbi I et al (2015) Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration. Integr Biol 7(10):1120\u20131134","journal-title":"Integr Biol"},{"issue":"10","key":"4_CR101","doi-asserted-by":"publisher","first-page":"e3831","DOI":"10.1002\/nbm.3831","volume":"31","author":"CT Mierke","year":"2018","unstructured":"Mierke CT et al (2018) The two faces of enhanced stroma: Stroma acts as a tumor promoter and a steric obstacle. NMR Biomed 31(10):e3831","journal-title":"NMR Biomed"},{"issue":"4","key":"4_CR102","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1007\/s13277-013-1511-7","volume":"35","author":"M Fang","year":"2014","unstructured":"Fang M et al (2014) Collagen as a double-edged sword in tumor progression. Tumor Biol 35(4):2871\u20132882","journal-title":"Tumor Biol"},{"issue":"9","key":"4_CR103","doi-asserted-by":"publisher","first-page":"14348","DOI":"10.1002\/jcb.28669","volume":"120","author":"M Yu","year":"2019","unstructured":"Yu M et al (2019) Upregulated LOX and increased collagen content associated with aggressive clinicopathological features and unfavorable outcome in oral squamous cell carcinoma. J Cell Biochem 120(9):14348\u201314359","journal-title":"J Cell Biochem"},{"issue":"12","key":"4_CR104","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nrm3904","volume":"15","author":"C Bonnans","year":"2014","unstructured":"Bonnans C, Chou J, Werb Z (2014) Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol 15(12):786\u2013801","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"4_CR105","first-page":"85","volume":"25","author":"E Witsch","year":"2010","unstructured":"Witsch E, Sela M, Yarden Y (2010) Roles for growth factors in cancer progression. Physiology (Bethesda) 25(2):85\u2013101","journal-title":"Physiology (Bethesda)"},{"issue":"7","key":"4_CR106","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/bjc.2016.255","volume":"115","author":"C Bellomo","year":"2016","unstructured":"Bellomo C, Caja L, Moustakas A (2016) Transforming growth factor beta as regulator of cancer stemness and metastasis. Br J Cancer 115(7):761\u2013769","journal-title":"Br J Cancer"},{"issue":"1","key":"4_CR107","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/01.ju.0000141582.15218.10","volume":"173","author":"LWK Chung","year":"2005","unstructured":"Chung LWK et al (2005) Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. J Urol 173(1):10\u201320","journal-title":"J Urol"},{"issue":"19","key":"4_CR108","doi-asserted-by":"publisher","first-page":"7022","DOI":"10.1158\/0008-5472.CAN-04-1449","volume":"64","author":"J Wyckoff","year":"2004","unstructured":"Wyckoff J et al (2004) A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 64(19):7022\u20137029","journal-title":"Cancer Res"},{"issue":"3","key":"4_CR109","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s12079-016-0347-5","volume":"10","author":"I Ubink","year":"2016","unstructured":"Ubink I et al (2016) A potential role for CCN2\/CTGF in aggressive colorectal cancer. J Cell Commun Signal 10(3):223\u2013227","journal-title":"J Cell Commun Signal"},{"issue":"38","key":"4_CR110","doi-asserted-by":"publisher","first-page":"61107","DOI":"10.18632\/oncotarget.11243","volume":"7","author":"JM Cathcart","year":"2016","unstructured":"Cathcart JM et al (2016) Interleukin-6 increases matrix metalloproteinase-14 (MMP-14) levels via down-regulation of p53 to drive cancer progression. Oncotarget 7(38):61107\u201361120","journal-title":"Oncotarget"},{"issue":"6","key":"4_CR111","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x20176104","volume":"50","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Chen Q (2017) Relationship between matrix metalloproteinases and the occurrence and development of ovarian cancer. Braz J Med Biol Res 50(6):e6104","journal-title":"Braz J Med Biol Res"},{"key":"4_CR112","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.csbj.2018.07.003","volume":"16","author":"B Emon","year":"2018","unstructured":"Emon B et al (2018) Biophysics of tumor microenvironment and cancer metastasis \u2013 a mini review. Comput Struct Biotechnol J 16:279\u2013287","journal-title":"Comput Struct Biotechnol J"},{"issue":"11","key":"4_CR113","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.7150\/ijbs.21230","volume":"13","author":"B Wei","year":"2017","unstructured":"Wei B et al (2017) Human colorectal cancer progression correlates with LOX-induced ECM stiffening. Int J Biol Sci 13(11):1450\u20131457","journal-title":"Int J Biol Sci"},{"issue":"3","key":"4_CR114","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009808","volume":"5","author":"IJ Huijbers","year":"2010","unstructured":"Huijbers IJ et al (2010) A role for fibrillar collagen deposition and the collagen internalization receptor endo180 in glioma invasion. PLoS One 5(3):e9808","journal-title":"PLoS One"},{"issue":"1","key":"4_CR115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15476278.2015.1019687","volume":"11","author":"AM Handorf","year":"2015","unstructured":"Handorf AM et al (2015) Tissue stiffness dictates development, homeostasis, and disease progression. Organogenesis 11(1):1\u201315","journal-title":"Organogenesis"},{"issue":"1","key":"4_CR116","doi-asserted-by":"crossref","first-page":"jcs209619","DOI":"10.1242\/jcs.209619","volume":"131","author":"E Ventura","year":"2018","unstructured":"Ventura E et al (2018) TGF-beta induces oncofetal fibronectin that, in turn, modulates TGF-beta superfamily signaling in endothelial cells. J Cell Sci 131(1):jcs209619","journal-title":"J Cell Sci"},{"issue":"18","key":"4_CR117","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1016\/S0959-8049(02)00210-1","volume":"38","author":"E Ioachim","year":"2002","unstructured":"Ioachim E et al (2002) Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression. Eur J Cancer 38(18):2362\u20132370","journal-title":"Eur J Cancer"},{"issue":"3","key":"4_CR118","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00432-018-2580-1","volume":"144","author":"G Karpinsky","year":"2018","unstructured":"Karpinsky G et al (2018) Tumor expression of survivin, p53, cyclin D1, osteopontin and fibronectin in predicting the response to neo-adjuvant chemotherapy in children with advanced malignant peripheral nerve sheath tumor. J Cancer Res Clin Oncol 144(3):519\u2013529","journal-title":"J Cancer Res Clin Oncol"},{"issue":"11","key":"4_CR119","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1007\/s00018-008-7584-6","volume":"65","author":"NJ Nasser","year":"2008","unstructured":"Nasser NJ (2008) Heparanase involvement in physiology and disease. Cell Mol Life Sci 65(11):1706\u20131715","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"4_CR120","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.ejca.2010.02.024","volume":"46","author":"V Orian-Rousseau","year":"2010","unstructured":"Orian-Rousseau V (2010) CD44, a therapeutic target for metastasising tumours. Eur J Cancer 46(7):1271\u20131277","journal-title":"Eur J Cancer"},{"issue":"2","key":"4_CR121","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1152\/physiol.00045.2009","volume":"25","author":"E Witsch","year":"2010","unstructured":"Witsch E, Sela M, Yarden Y (2010) Roles for growth factors in cancer progression. Physiology 25(2):85\u2013101","journal-title":"Physiology"},{"issue":"1","key":"4_CR122","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3190-z","volume":"17","author":"JA de la Mare","year":"2017","unstructured":"de la Mare JA, Jurgens T, Edkins AL (2017) Extracellular Hsp90 and TGFbeta regulate adhesion, migration and anchorage independent growth in a paired colon cancer cell line model. BMC Cancer 17(1):202","journal-title":"BMC Cancer"},{"issue":"5","key":"4_CR123","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1165\/rcmb.2015-0020TR","volume":"53","author":"VJ Craig","year":"2015","unstructured":"Craig VJ et al (2015) Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 53(5):585\u2013600","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"4_CR124","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","volume":"141","author":"K Kessenbrock","year":"2010","unstructured":"Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141(1):52\u201367","journal-title":"Cell"},{"key":"4_CR125","doi-asserted-by":"crossref","unstructured":"Wang TH, Hsia SM, Shieh TM (2016) Lysyl oxidase and the tumor microenvironment. Int J Mol Sci 18(1)","DOI":"10.3390\/ijms18010062"},{"issue":"6","key":"4_CR126","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1158\/0008-5472.CAN-12-2233","volume":"73","author":"TR Cox","year":"2013","unstructured":"Cox TR et al (2013) LOX-mediated collagen crosslinking is responsible for fibrosis-enhanced metastasis. Cancer Res 73(6):1721\u20131732","journal-title":"Cancer Res"},{"issue":"11","key":"4_CR127","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.7150\/ijbs.16405","volume":"12","author":"CL Qi","year":"2016","unstructured":"Qi CL et al (2016) P-selectin-mediated LOX expression promotes insulinoma growth in Rip1-Tag2 mice by increasing tissue stiffness. Int J Biol Sci 12(11):1289\u20131297","journal-title":"Int J Biol Sci"},{"issue":"19","key":"4_CR128","doi-asserted-by":"publisher","first-page":"4482","DOI":"10.1158\/1078-0432.CCR-15-0226","volume":"21","author":"J Lee","year":"2015","unstructured":"Lee J et al (2015) Tissue transglutaminase mediated tumor-stroma interaction promotes pancreatic cancer progression. Clin Cancer Res 21(19):4482\u20134493","journal-title":"Clin Cancer Res"},{"key":"4_CR129","doi-asserted-by":"crossref","unstructured":"Previtera ML, Sengupta A (2015) Substrate stiffness regulates proinflammatory mediator production through TLR4 activity in macrophages. PLoS One 10(12)","DOI":"10.1371\/journal.pone.0145813"},{"issue":"5","key":"4_CR130","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.copbio.2011.04.007","volume":"22","author":"AW Holle","year":"2011","unstructured":"Holle AW, Engler AJ (2011) More than a feeling: discovering, understanding, and influencing mechanosensing pathways. Curr Opin Biotechnol 22(5):648\u2013654","journal-title":"Curr Opin Biotechnol"},{"key":"4_CR131","doi-asserted-by":"publisher","first-page":"15321","DOI":"10.1038\/ncomms15321","volume":"8","author":"G Nardone","year":"2017","unstructured":"Nardone G et al (2017) YAP regulates cell mechanics by controlling focal adhesion assembly. Nat Commun 8:15321","journal-title":"Nat Commun"},{"issue":"1","key":"4_CR132","first-page":"jcs224360","volume":"132","author":"BF Matte","year":"2019","unstructured":"Matte BF et al (2019) Matrix stiffness mechanically conditions EMT and migratory behavior of oral squamous cell carcinoma. J Cell Sci 132(1):jcs224360","journal-title":"J Cell Sci"},{"issue":"5","key":"4_CR133","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/ncb3157","volume":"17","author":"SC Wei","year":"2015","unstructured":"Wei SC et al (2015) Matrix stiffness drives epithelial mesenchymal transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway. Nat Cell Biol 17(5):678\u2013U306","journal-title":"Nat Cell Biol"},{"issue":"5","key":"4_CR134","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.cell.2005.05.019","volume":"121","author":"DR Green","year":"2005","unstructured":"Green DR (2005) Apoptotic pathways: ten minutes to dead. Cell 121(5):671\u2013674","journal-title":"Cell"},{"issue":"5","key":"4_CR135","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s40291-014-0104-5","volume":"18","author":"A Jain","year":"2014","unstructured":"Jain A et al (2014) Oncoapoptotic markers in oral cancer: prognostics and therapeutic perspective. Mol Diagn Ther 18(5):483\u2013494","journal-title":"Mol Diagn Ther"},{"key":"4_CR136","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12943-015-0321-5","volume":"14","author":"Z Su","year":"2015","unstructured":"Su Z et al (2015) Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol Cancer 14:48","journal-title":"Mol Cancer"},{"issue":"5","key":"4_CR137","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.7150\/thno.18551","volume":"7","author":"SC Su","year":"2017","unstructured":"Su SC et al (2017) Exome sequencing of oral squamous cell carcinoma reveals molecular subgroups and novel therapeutic opportunities. Theranostics 7(5):1088\u20131099","journal-title":"Theranostics"},{"issue":"7","key":"4_CR138","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1158\/2159-8290.CD-12-0537","volume":"3","author":"CR Pickering","year":"2013","unstructured":"Pickering CR et al (2013) Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers. Cancer Discov 3(7):770\u2013781","journal-title":"Cancer Discov"},{"issue":"9","key":"4_CR139","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1111\/j.1365-4632.2012.05525.x","volume":"52","author":"YB Lee","year":"2013","unstructured":"Lee YB et al (2013) Expression of Fas and Fas ligand in primary cutaneous squamous cell carcinoma in association with grade of tumor differentiation. Int J Dermatol 52(9):1092\u20131097","journal-title":"Int J Dermatol"},{"key":"4_CR140","first-page":"54","volume":"134","author":"SN Das","year":"2011","unstructured":"Das SN et al (2011) Fas receptor (CD95) & Fas ligand (CD178) expression in patients with tobacco-related intraoral squamous cell carcinoma. Indian J Med Res 134:54\u201360","journal-title":"Indian J Med Res"},{"issue":"6","key":"4_CR141","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/S1368-8375(99)00029-9","volume":"35","author":"Q Chen","year":"1999","unstructured":"Chen Q et al (1999) Up-regulation of Fas ligand and down-regulation of Fas expression in oral carcinogenesis. Oral Oncol 35(6):548\u2013553","journal-title":"Oral Oncol"},{"issue":"3","key":"4_CR142","first-page":"487","volume":"14","author":"M Hadzi-Mihailovic","year":"2009","unstructured":"Hadzi-Mihailovic M et al (2009) Expression of Fas\/FasL in patients with oral lichen planus. J BUON 14(3):487\u2013493","journal-title":"J BUON"},{"issue":"3","key":"4_CR143","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1600-0714.2008.00689.x","volume":"38","author":"M Zhang","year":"2009","unstructured":"Zhang M et al (2009) Prognostic significance of Bcl-2 and Bax protein expression in the patients with oral squamous cell carcinoma. J Oral Pathol Med 38(3):307\u2013313","journal-title":"J Oral Pathol Med"},{"issue":"3","key":"4_CR144","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.oraloncology.2008.05.021","volume":"45","author":"DR Camisasca","year":"2009","unstructured":"Camisasca DR et al (2009) Expression of Bcl-2 family proteins and associated clinicopathologic factors predict survival outcome in patients with oral squamous cell carcinoma. Oral Oncol 45(3):225\u2013233","journal-title":"Oral Oncol"},{"issue":"11","key":"4_CR145","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1002\/(SICI)1097-0142(19970601)79:11<2200::AID-CNCR19>3.0.CO;2-#","volume":"79","author":"X Xie","year":"1997","unstructured":"Xie X et al (1997) Diagnostic and prognostic value of nucleolar organizer regions in normal epithelium, dysplasia, and squamous cell carcinoma of the oral cavity. Cancer 79(11):2200\u20132208","journal-title":"Cancer"},{"issue":"4","key":"4_CR146","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.tripleo.2010.04.009","volume":"110","author":"L Su","year":"2010","unstructured":"Su L et al (2010) Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 110(4):484\u2013491","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"5","key":"4_CR147","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1600-0714.2009.00844.x","volume":"39","author":"YH Kim","year":"2010","unstructured":"Kim YH et al (2010) Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma. J Oral Pathol Med 39(5):368\u2013375","journal-title":"J Oral Pathol Med"},{"issue":"12","key":"4_CR148","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1038\/sj.bjc.6601402","volume":"89","author":"L Lo Muzio","year":"2003","unstructured":"Lo Muzio L et al (2003) Survivin expression in oral squamous cell carcinoma. Br J Cancer 89(12):2244\u20132248","journal-title":"Br J Cancer"},{"issue":"7","key":"4_CR149","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/S1368-8375(03)00049-6","volume":"39","author":"EA Swan","year":"2003","unstructured":"Swan EA et al (2003) Acquisition of anoikis resistance is a critical step in the progression of oral tongue cancer. Oral Oncol 39(7):648\u2013655","journal-title":"Oral Oncol"},{"issue":"1","key":"4_CR150","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cden.2017.08.006","volume":"62","author":"L Hartner","year":"2018","unstructured":"Hartner L (2018) Chemotherapy for oral cancer. Dent Clin N Am 62(1):87\u201397","journal-title":"Dent Clin N Am"},{"issue":"1","key":"4_CR151","first-page":"25","volume":"19","author":"C Wang","year":"2016","unstructured":"Wang C et al (2016) Molecular mechanisms of chemoresistance in oral cancer. Chin J Dent Res 19(1):25\u201333","journal-title":"Chin J Dent Res"},{"key":"4_CR152","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-6-224","volume":"6","author":"P Zhang","year":"2006","unstructured":"Zhang P et al (2006) Identification of genes associated with cisplatin resistance in human oral squamous cell carcinoma cell line. BMC Cancer 6:224","journal-title":"BMC Cancer"},{"issue":"1","key":"4_CR153","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S1368-8375(00)00098-1","volume":"38","author":"T Noutomi","year":"2002","unstructured":"Noutomi T et al (2002) Bcl-x(L) confers multi-drug resistance in several squamous cell carcinoma cell lines. Oral Oncol 38(1):41\u201348","journal-title":"Oral Oncol"},{"key":"4_CR154","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-015-0130-x","volume":"8","author":"H Wang","year":"2015","unstructured":"Wang H et al (2015) Small-molecule inhibitor of Bcl-2 (TW-37) suppresses growth and enhances cisplatin-induced apoptosis in ovarian cancer cells. J Ovarian Res 8:3","journal-title":"J Ovarian Res"},{"issue":"8","key":"4_CR155","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S1368-8375(02)00047-7","volume":"38","author":"M Itoh","year":"2002","unstructured":"Itoh M et al (2002) BcI-xL antisense treatment sensitizes Bcl-xL-overexpressing squamous cell carcinoma cells to carboplatin. Oral Oncol 38(8):752\u2013756","journal-title":"Oral Oncol"},{"issue":"11","key":"4_CR156","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1177\/154405910308201115","volume":"82","author":"L Lo Muzio","year":"2003","unstructured":"Lo Muzio L et al (2003) Survivin, a potential early predictor of tumor progression in the oral mucosa. J Dent Res 82(11):923\u2013928","journal-title":"J Dent Res"},{"issue":"3","key":"4_CR157","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1006\/exmp.2001.2367","volume":"70","author":"L Lo Muzio","year":"2001","unstructured":"Lo Muzio L et al (2001) Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. Exp Mol Pathol 70(3):249\u2013254","journal-title":"Exp Mol Pathol"},{"issue":"6","key":"4_CR158","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1002\/ijc.22941","volume":"121","author":"BM Lippert","year":"2007","unstructured":"Lippert BM et al (2007) Dynamic survivin in head and neck cancer: molecular mechanism and therapeutic potential. Int J Cancer 121(6):1169\u20131174","journal-title":"Int J Cancer"},{"issue":"5","key":"4_CR159","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/path.2134","volume":"211","author":"K Engels","year":"2007","unstructured":"Engels K et al (2007) Dynamic intracellular survivin in oral squamous cell carcinoma: underlying molecular mechanism and potential as an early prognostic marker. J Pathol 211(5):532\u2013540","journal-title":"J Pathol"},{"issue":"8","key":"4_CR160","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3727\/096504010X12644422320663","volume":"18","author":"JH Xu","year":"2010","unstructured":"Xu JH et al (2010) Survivin shRNA induces caspase-3-dependent apoptosis and enhances cisplatin sensitivity in squamous cell carcinoma of the tongue. Oncol Res 18(8):377\u2013385","journal-title":"Oncol Res"},{"issue":"8","key":"4_CR161","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.ijom.2007.05.016","volume":"36","author":"J Xu","year":"2007","unstructured":"Xu J et al (2007) Nicotine inhibits apoptosis induced by cisplatin in human oral cancer cells. Int J Oral Maxillofac Surg 36(8):739\u2013744","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"5","key":"4_CR162","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1200\/JCO.2009.22.4170","volume":"28","author":"F Perrone","year":"2010","unstructured":"Perrone F et al (2010) TP53 mutations and pathologic complete response to neoadjuvant cisplatin and fluorouracil chemotherapy in resected oral cavity squamous cell carcinoma. J Clin Oncol 28(5):761\u2013766","journal-title":"J Clin Oncol"},{"issue":"3","key":"4_CR163","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1080\/02841860600547380","volume":"45","author":"E Henriksson","year":"2006","unstructured":"Henriksson E et al (2006) p53 mutation and cyclin D1 amplification correlate with cisplatin sensitivity in xenografted human squamous cell carcinomas from head and neck. Acta Oncol 45(3):300\u2013305","journal-title":"Acta Oncol"},{"issue":"2","key":"4_CR164","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1200\/JCO.2000.18.2.385","volume":"18","author":"S Temam","year":"2000","unstructured":"Temam S et al (2000) p53 gene status as a predictor of tumor response to induction chemotherapy of patients with locoregionally advanced squamous cell carcinomas of the head and neck. J Clin Oncol 18(2):385\u2013394","journal-title":"J Clin Oncol"},{"issue":"10","key":"4_CR165","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1007\/s00432-014-1727-y","volume":"140","author":"M Tonigold","year":"2014","unstructured":"Tonigold M et al (2014) A cisplatin-resistant head and neck cancer cell line with cytoplasmic p53(mut) exhibits ATP-binding cassette transporter upregulation and high glutathione levels. J Cancer Res Clin Oncol 140(10):1689\u20131704","journal-title":"J Cancer Res Clin Oncol"},{"issue":"7534","key":"4_CR166","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature14191","volume":"517","author":"M Pasparakis","year":"2015","unstructured":"Pasparakis M, Vandenabeele P (2015) Necroptosis and its role in inflammation. Nature 517(7534):311\u2013320","journal-title":"Nature"},{"issue":"2","key":"4_CR167","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrm3737","volume":"15","author":"T Vanden Berghe","year":"2014","unstructured":"Vanden Berghe T et al (2014) Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat Rev Mol Cell Biol 15(2):135\u2013147","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"4_CR168","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/cdd.2017.65","volume":"24","author":"S Grootjans","year":"2017","unstructured":"Grootjans S, Vanden Berghe T, Vandenabeele P (2017) Initiation and execution mechanisms of necroptosis: an overview. Cell Death Differ 24(7):1184\u20131195","journal-title":"Cell Death Differ"},{"issue":"4","key":"4_CR169","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1177\/1533034616655909","volume":"16","author":"X Li","year":"2017","unstructured":"Li X et al (2017) Association of mixed lineage kinase domain-like protein expression with prognosis in patients with colon cancer. Technol Cancer Res Treat 16(4):428\u2013434","journal-title":"Technol Cancer Res Treat"},{"issue":"10","key":"4_CR170","doi-asserted-by":"publisher","first-page":"13679","DOI":"10.1007\/s13277-016-5229-1","volume":"37","author":"Z Ertao","year":"2016","unstructured":"Ertao Z et al (2016) Prognostic value of mixed lineage kinase domain-like protein expression in the survival of patients with gastric cancer. Tumour Biol 37(10):13679\u201313685","journal-title":"Tumour Biol"},{"issue":"11","key":"4_CR171","first-page":"15035","volume":"8","author":"J Ruan","year":"2015","unstructured":"Ruan J et al (2015) Mixed lineage kinase domain-like protein is a prognostic biomarker for cervical squamous cell cancer. Int J Clin Exp Pathol 8(11):15035\u201315038","journal-title":"Int J Clin Exp Pathol"},{"key":"4_CR172","first-page":"1539","volume":"6","author":"L He","year":"2013","unstructured":"He L et al (2013) Low expression of mixed lineage kinase domain-like protein is associated with poor prognosis in ovarian cancer patients. Onco Targets Ther 6:1539\u20131543","journal-title":"Onco Targets Ther"},{"issue":"17","key":"4_CR173","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1002\/cncr.28144","volume":"119","author":"LE Colbert","year":"2013","unstructured":"Colbert LE et al (2013) Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma. Cancer 119(17):3148\u20133155","journal-title":"Cancer"},{"issue":"8","key":"4_CR174","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.2005756","volume":"16","author":"A Najafov","year":"2018","unstructured":"Najafov A et al (2018) BRAF and AXL oncogenes drive RIPK3 expression loss in cancer. PLoS Biol 16(8):e2005756","journal-title":"PLoS Biol"},{"issue":"11\u201312","key":"4_CR175","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1007\/s00018-016-2193-2","volume":"73","author":"S Philipp","year":"2016","unstructured":"Philipp S, Sosna J, Adam D (2016) Cancer and necroptosis: friend or foe? Cell Mol Life Sci 73(11\u201312):2183\u20132193","journal-title":"Cell Mol Life Sci"},{"key":"4_CR176","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.2147\/OTT.S200740","volume":"12","author":"T Liu","year":"2019","unstructured":"Liu T, Sun X, Cao Z (2019) Shikonin-induced necroptosis in nasopharyngeal carcinoma cells via ROS overproduction and upregulation of RIPK1\/RIPK3\/MLKL expression. Onco Targets Ther 12:2605\u20132614","journal-title":"Onco Targets Ther"},{"issue":"3","key":"4_CR177","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1124\/jpet.112.200519","volume":"344","author":"N Pasupuleti","year":"2013","unstructured":"Pasupuleti N et al (2013) 5-Benzylglycinyl-amiloride kills proliferating and nonproliferating malignant glioma cells through caspase-independent necroptosis mediated by apoptosis-inducing factor. J Pharmacol Exp Ther 344(3):600\u2013615","journal-title":"J Pharmacol Exp Ther"},{"key":"4_CR178","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-580","volume":"13","author":"Z Fu","year":"2013","unstructured":"Fu Z et al (2013) The anti-tumor effect of shikonin on osteosarcoma by inducing RIP1 and RIP3 dependent necroptosis. BMC Cancer 13:580","journal-title":"BMC Cancer"},{"issue":"9","key":"4_CR179","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/cdd.2013.45","volume":"20","author":"F Basit","year":"2013","unstructured":"Basit F, Cristofanon S, Fulda S (2013) Obatoclax (GX15-070) triggers necroptosis by promoting the assembly of the necrosome on autophagosomal membranes. Cell Death Differ 20(9):1161\u20131173","journal-title":"Cell Death Differ"},{"issue":"12","key":"4_CR180","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.1002\/jcb.23314","volume":"112","author":"N Li","year":"2011","unstructured":"Li N et al (2011) D-galactose induces necroptotic cell death in neuroblastoma cell lines. J Cell Biochem 112(12):3834\u20133844","journal-title":"J Cell Biochem"},{"issue":"2","key":"4_CR181","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.canlet.2008.09.029","volume":"274","author":"Y Xuan","year":"2009","unstructured":"Xuan Y, Hu X (2009) Naturally-occurring shikonin analogues--a class of necroptotic inducers that circumvent cancer drug resistance. Cancer Lett 274(2):233\u2013242","journal-title":"Cancer Lett"},{"issue":"5","key":"4_CR182","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1158\/1535-7163.MCT-06-0511","volume":"6","author":"W Han","year":"2007","unstructured":"Han W et al (2007) Shikonin circumvents cancer drug resistance by induction of a necroptotic death. Mol Cancer Ther 6(5):1641\u20131649","journal-title":"Mol Cancer Ther"},{"issue":"26","key":"4_CR183","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.1038\/onc.2015.398","volume":"35","author":"M Oliver Metzig","year":"2016","unstructured":"Oliver Metzig M et al (2016) Inhibition of caspases primes colon cancer cells for 5-fluorouracil-induced TNF-alpha-dependent necroptosis driven by RIP1 kinase and NF-kappaB. Oncogene 35(26):3399\u20133409","journal-title":"Oncogene"},{"issue":"1","key":"4_CR184","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.canlet.2016.05.036","volume":"380","author":"S Hannes","year":"2016","unstructured":"Hannes S, Abhari BA, Fulda S (2016) Smac mimetic triggers necroptosis in pancreatic carcinoma cells when caspase activation is blocked. Cancer Lett 380(1):31\u201338","journal-title":"Cancer Lett"},{"issue":"1","key":"4_CR185","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05979-8","volume":"9","author":"L Van Hoecke","year":"2018","unstructured":"Van Hoecke L et al (2018) Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes. Nat Commun 9(1):3417","journal-title":"Nat Commun"},{"issue":"6","key":"4_CR186","volume":"5","author":"H Yang","year":"2016","unstructured":"Yang H et al (2016) Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy. Onco Targets Ther 5(6):e1149673","journal-title":"Onco Targets Ther"},{"issue":"2","key":"4_CR187","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.celrep.2016.03.037","volume":"15","author":"TL Aaes","year":"2016","unstructured":"Aaes TL et al (2016) Vaccination with necroptotic cancer cells induces efficient anti-tumor immunity. Cell Rep 15(2):274\u2013287","journal-title":"Cell Rep"},{"issue":"7598","key":"4_CR188","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nature17403","volume":"532","author":"L Seifert","year":"2016","unstructured":"Seifert L et al (2016) The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression. Nature 532(7598):245\u2013249","journal-title":"Nature"},{"issue":"7725","key":"4_CR189","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41586-018-0519-y","volume":"562","author":"M Seehawer","year":"2018","unstructured":"Seehawer M et al (2018) Necroptosis microenvironment directs lineage commitment in liver cancer. Nature 562(7725):69\u201375","journal-title":"Nature"},{"issue":"8","key":"4_CR190","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/s41422-018-0058-y","volume":"28","author":"D Jiao","year":"2018","unstructured":"Jiao D et al (2018) Necroptosis of tumor cells leads to tumor necrosis and promotes tumor metastasis. Cell Res 28(8):868\u2013870","journal-title":"Cell Res"},{"issue":"8","key":"4_CR191","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/cr.2016.87","volume":"26","author":"Z Cai","year":"2016","unstructured":"Cai Z et al (2016) Activation of cell-surface proteases promotes necroptosis, inflammation and cell migration. Cell Res 26(8):886\u2013900","journal-title":"Cell Res"},{"issue":"14","key":"4_CR192","doi-asserted-by":"publisher","first-page":"3844","DOI":"10.1073\/pnas.1602023113","volume":"113","author":"S Hangai","year":"2016","unstructured":"Hangai S et al (2016) PGE2 induced in and released by dying cells functions as an inhibitory DAMP. Proc Natl Acad Sci U S A 113(14):3844\u20133849","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR193","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.freeradbiomed.2018.10.426","volume":"129","author":"D Shin","year":"2018","unstructured":"Shin D et al (2018) Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer. Free Radic Biol Med 129:454\u2013462","journal-title":"Free Radic Biol Med"},{"key":"4_CR194","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.canlet.2018.06.018","volume":"432","author":"EH Kim","year":"2018","unstructured":"Kim EH et al (2018) CISD2 inhibition overcomes resistance to sulfasalazine-induced ferroptotic cell death in head and neck cancer. Cancer Lett 432:180\u2013190","journal-title":"Cancer Lett"},{"key":"4_CR195","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.redox.2016.12.010","volume":"11","author":"JL Roh","year":"2017","unstructured":"Roh JL et al (2017) Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis. Redox Biol 11:254\u2013262","journal-title":"Redox Biol"},{"issue":"1","key":"4_CR196","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.canlet.2016.07.035","volume":"381","author":"JL Roh","year":"2016","unstructured":"Roh JL et al (2016) Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer. Cancer Lett 381(1):96\u2013103","journal-title":"Cancer Lett"},{"issue":"1","key":"4_CR197","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.canlet.2016.07.033","volume":"381","author":"R Lin","year":"2016","unstructured":"Lin R et al (2016) Dihydroartemisinin (DHA) induces ferroptosis and causes cell cycle arrest in head and neck carcinoma cells. Cancer Lett 381(1):165\u2013175","journal-title":"Cancer Lett"},{"key":"4_CR198","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.phymed.2018.09.223","volume":"56","author":"E Yue","year":"2019","unstructured":"Yue E et al (2019) Anthocyanin is involved in the activation of pyroptosis in oral squamous cell carcinoma. Phytomedicine 56:286\u2013294","journal-title":"Phytomedicine"},{"issue":"12","key":"4_CR199","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/onc.2016.333","volume":"36","author":"EE Mowers","year":"2017","unstructured":"Mowers EE, Sharifi MN, Macleod KF (2017) Autophagy in cancer metastasis. Oncogene 36(12):1619\u20131630","journal-title":"Oncogene"},{"key":"4_CR200","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.oraloncology.2015.12.007","volume":"54","author":"B Cosway","year":"2016","unstructured":"Cosway B, Lovat P (2016) The role of autophagy in squamous cell carcinoma of the head and neck. Oral Oncol 54:1\u20136","journal-title":"Oral Oncol"},{"key":"4_CR201","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.oraloncology.2016.09.001","volume":"61","author":"N Adhauliya","year":"2016","unstructured":"Adhauliya N et al (2016) Autophagy: A boon or bane in oral cancer. Oral Oncol 61:120\u2013126","journal-title":"Oral Oncol"},{"issue":"5","key":"4_CR202","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/bjc.2014.355","volume":"111","author":"JL Liu","year":"2014","unstructured":"Liu JL et al (2014) Prognostic significance of p62\/SQSTM1 subcellular localization and LC3B in oral squamous cell carcinoma. Br J Cancer 111(5):944\u2013954","journal-title":"Br J Cancer"},{"issue":"5","key":"4_CR203","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1038\/jid.2013.497","volume":"134","author":"RA Ellis","year":"2014","unstructured":"Ellis RA et al (2014) Prognostic impact of p62 expression in cutaneous malignant melanoma. J Invest Dermatol 134(5):1476\u20131478","journal-title":"J Invest Dermatol"},{"issue":"9","key":"4_CR204","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074398","volume":"8","author":"T Inui","year":"2013","unstructured":"Inui T et al (2013) Association of p62\/SQSTM1 excess and oral carcinogenesis. PLoS One 8(9):e74398","journal-title":"PLoS One"},{"issue":"1","key":"4_CR205","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cas.12559","volume":"106","author":"K Sakakura","year":"2015","unstructured":"Sakakura K et al (2015) Immunological significance of the accumulation of autophagy components in oral squamous cell carcinoma. Cancer Sci 106(1):1\u20138","journal-title":"Cancer Sci"},{"issue":"11","key":"4_CR206","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1016\/j.humpath.2013.06.017","volume":"44","author":"JY Tang","year":"2013","unstructured":"Tang JY et al (2013) High LC3 expression correlates with poor survival in patients with oral squamous cell carcinoma. Hum Pathol 44(11):2558\u20132562","journal-title":"Hum Pathol"},{"issue":"10","key":"4_CR207","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.oraloncology.2014.06.020","volume":"50","author":"J Weng","year":"2014","unstructured":"Weng J et al (2014) Beclin1 inhibits proliferation, migration and invasion in tongue squamous cell carcinoma cell lines. Oral Oncol 50(10):983\u2013990","journal-title":"Oral Oncol"},{"issue":"2","key":"4_CR208","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/jop.12102","volume":"43","author":"CY Yen","year":"2014","unstructured":"Yen CY et al (2014) Long-term stimulation of areca nut components results in increased chemoresistance through elevated autophagic activity. J Oral Pathol Med 43(2):91\u201396","journal-title":"J Oral Pathol Med"},{"key":"4_CR209","doi-asserted-by":"publisher","first-page":"e1771","DOI":"10.1038\/cddis.2015.139","volume":"6","author":"L Zhang","year":"2015","unstructured":"Zhang L et al (2015) Dual induction of apoptotic and autophagic cell death by targeting survivin in head neck squamous cell carcinoma. Cell Death Dis 6:e1771","journal-title":"Cell Death Dis"},{"issue":"6","key":"4_CR210","doi-asserted-by":"publisher","first-page":"725","DOI":"10.4161\/auto.6.6.12423","volume":"6","author":"HH Lu","year":"2010","unstructured":"Lu HH et al (2010) Areca nut extract induced oxidative stress and upregulated hypoxia inducing factor leading to autophagy in oral cancer cells. Autophagy 6(6):725\u2013737","journal-title":"Autophagy"},{"issue":"8","key":"4_CR211","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.archoralbio.2012.04.005","volume":"57","author":"JY Kim","year":"2012","unstructured":"Kim JY et al (2012) Curcumin-induced autophagy contributes to the decreased survival of oral cancer cells. Arch Oral Biol 57(8):1018\u20131025","journal-title":"Arch Oral Biol"},{"issue":"2","key":"4_CR212","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3892\/ijo.2013.1952","volume":"43","author":"AC Huang","year":"2013","unstructured":"Huang AC et al (2013) Tetrandrine induces cell death in SAS human oral cancer cells through caspase activation-dependent apoptosis and LC3-I and LC3-II activation-dependent autophagy. Int J Oncol 43(2):485\u2013494","journal-title":"Int J Oncol"},{"issue":"16","key":"4_CR213","doi-asserted-by":"publisher","first-page":"6939","DOI":"10.7314\/APJCP.2014.15.16.6939","volume":"15","author":"HY Han","year":"2014","unstructured":"Han HY et al (2014) Sulfasalazine induces autophagic cell death in oral cancer cells via Akt and ERK pathways. Asian Pac J Cancer Prev 15(16):6939\u20136944","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"4_CR214","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1600-0714.2012.01187.x","volume":"42","author":"MY Ahn","year":"2013","unstructured":"Ahn MY et al (2013) Synthesized Pheophorbide a-mediated photodynamic therapy induced apoptosis and autophagy in human oral squamous carcinoma cells. J Oral Pathol Med 42(1):17\u201325","journal-title":"J Oral Pathol Med"},{"issue":"36","key":"4_CR215","doi-asserted-by":"publisher","first-page":"58075","DOI":"10.18632\/oncotarget.10873","volume":"7","author":"KH Chi","year":"2016","unstructured":"Chi KH et al (2016) Simultaneous activation and inhibition of autophagy sensitizes cancer cells to chemotherapy. Oncotarget 7(36):58075\u201358088","journal-title":"Oncotarget"},{"issue":"12","key":"4_CR216","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.2105\/AJPH.2005.078436","volume":"96","author":"TM Brown","year":"2006","unstructured":"Brown TM, Fee E (2006) Rudolf Carl Virchow: medical scientist, social reformer, role model. Am J Public Health 96(12):2104\u20132105","journal-title":"Am J Public Health"},{"issue":"3","key":"4_CR217","first-page":"355","volume":"34","author":"SI Hajdu","year":"2004","unstructured":"Hajdu SI (2004) The first tumor pathologist. Ann Clin Lab Sci 34(3):355\u2013356","journal-title":"Ann Clin Lab Sci"},{"issue":"2","key":"4_CR218","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","volume":"15","author":"I Dagogo-Jack","year":"2018","unstructured":"Dagogo-Jack I, Shaw AT (2018) Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol 15(2):81\u201394","journal-title":"Nat Rev Clin Oncol"},{"key":"4_CR219","doi-asserted-by":"crossref","unstructured":"Yuan YY (2016) Spatial heterogeneity in the tumor microenvironment. Cold Spring Harb Perspect Med 6(8)","DOI":"10.1101\/cshperspect.a026583"},{"key":"4_CR220","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.arr.2017.08.003","volume":"40","author":"JM Campbell","year":"2017","unstructured":"Campbell JM et al (2017) Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis. Ageing Res Rev 40:31\u201344","journal-title":"Ageing Res Rev"},{"issue":"5\u20136","key":"4_CR221","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1159\/000024515","volume":"18","author":"S Nakayama","year":"1998","unstructured":"Nakayama S et al (1998) Establishment of high and low metastasis cell lines derived from a human tongue squamous cell carcinoma. Invasion Metastasis 18(5\u20136):219\u2013228","journal-title":"Invasion Metastasis"},{"issue":"2","key":"4_CR222","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.joms.2018.09.014","volume":"77","author":"A Gabusi","year":"2019","unstructured":"Gabusi A et al (2019) Intratumoral heterogeneity in recurrent metastatic squamous cell carcinoma of the oral cavity: new perspectives afforded by multiregion DNA sequencing and mtDNA analysis. J Oral Maxillofac Surg 77(2):440\u2013455","journal-title":"J Oral Maxillofac Surg"},{"issue":"4","key":"4_CR223","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","volume":"168","author":"N McGranahan","year":"2017","unstructured":"McGranahan N, Swanton C (2017) Clonal heterogeneity and tumor evolution: past, present, and the future. Cell 168(4):613\u2013628","journal-title":"Cell"},{"issue":"7","key":"4_CR224","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.cell.2017.10.044","volume":"171","author":"SV Puram","year":"2017","unstructured":"Puram SV et al (2017) Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer. Cell 171(7):1611\u20131624 e24","journal-title":"Cell"},{"issue":"7","key":"4_CR225","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1158\/2159-8290.CD-18-1522","volume":"9","author":"E Driehuis","year":"2019","unstructured":"Driehuis E et al (2019) Oral mucosal organoids as a potential platform for personalized cancer therapy. Cancer Discov 9(7):852\u2013871","journal-title":"Cancer Discov"},{"key":"4_CR226","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.oraloncology.2018.10.018","volume":"87","author":"N Tanaka","year":"2018","unstructured":"Tanaka N et al (2018) Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity. Oral Oncol 87:49\u201357","journal-title":"Oral Oncol"},{"issue":"4260","key":"4_CR227","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1126\/science.959840","volume":"194","author":"N PC","year":"1976","unstructured":"PC N (1976) The clonal evolution of tumor cell populations. Science (NY) 194(4260):23\u201328","journal-title":"Science (NY)"},{"key":"4_CR228","doi-asserted-by":"crossref","unstructured":"Dylawerska A et al (2017) Association of DNA repair genes polymorphisms and mutations with increased risk of head and neck cancer: a review. Med Oncol 34(12)","DOI":"10.1007\/s12032-017-1057-4"},{"issue":"7","key":"4_CR229","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1600-0714.2008.00643.x","volume":"37","author":"MT Teh","year":"2008","unstructured":"Teh MT et al (2008) Fingerprinting genomic instability in oral submucous fibrosis. J Oral Pathol Med 37(7):430\u2013436","journal-title":"J Oral Pathol Med"},{"key":"4_CR230","doi-asserted-by":"crossref","unstructured":"Sharma A et al (2018) Longitudinal single-cell RNA sequencing of patient-derived primary cells reveals drug-induced infidelity in stem cell hierarchy. Nat Commun 9","DOI":"10.1038\/s41467-018-07261-3"},{"key":"4_CR231","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ejca.2018.01.064","volume":"93","author":"T Melchardt","year":"2018","unstructured":"Melchardt T et al (2018) Clonal evolution and heterogeneity in metastatic head and neck cancer \u2013 an analysis of the Austrian Study Group of Medical Tumour Therapy study group. Eur J Cancer 93:69\u201378","journal-title":"Eur J Cancer"},{"issue":"1","key":"4_CR232","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1158\/1078-0432.CCR-17-2410","volume":"24","author":"F Niehr","year":"2018","unstructured":"Niehr F et al (2018) Multilayered omics-based analysis of a head and neck cancer model of cisplatin resistance reveals intratumoral heterogeneity and treatment-induced clonal selection. Clin Cancer Res 24(1):158\u2013168","journal-title":"Clin Cancer Res"},{"issue":"3","key":"4_CR233","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nm.2304","volume":"17","author":"H Clevers","year":"2011","unstructured":"Clevers H (2011) The cancer stem cell: premises, promises and challenges. Nat Med 17(3):313\u2013319","journal-title":"Nat Med"},{"issue":"1","key":"4_CR234","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0600-4","volume":"16","author":"PR Prasetyanti","year":"2017","unstructured":"Prasetyanti PR, Medema JP (2017) Intra-tumor heterogeneity from a cancer stem cell perspective. Mol Cancer 16(1):41","journal-title":"Mol Cancer"},{"issue":"2","key":"4_CR235","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.canlet.2009.08.010","volume":"289","author":"QZ Zhang","year":"2010","unstructured":"Zhang QZ et al (2010) A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy. Cancer Lett 289(2):151\u2013160","journal-title":"Cancer Lett"},{"issue":"1","key":"4_CR236","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3892\/ijo.2015.3261","volume":"48","author":"K Todoroki","year":"2016","unstructured":"Todoroki K et al (2016) CD44v3(+)\/CD24(\u2212) cells possess cancer stem cell-like properties in human oral squamous cell carcinoma. Int J Oncol 48(1):99\u2013109","journal-title":"Int J Oncol"},{"issue":"5","key":"4_CR237","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.3892\/mmr.2014.3133","volume":"11","author":"YT Liu","year":"2015","unstructured":"Liu YT et al (2015) Isolation and phenotypic characterization of side population cells in oral squamous cell carcinoma. Mol Med Rep 11(5):3642\u20133646","journal-title":"Mol Med Rep"},{"issue":"2","key":"4_CR238","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.canlet.2013.06.011","volume":"338","author":"V Richard","year":"2013","unstructured":"Richard V et al (2013) Multiple drug resistant, tumorigenic stem-like cells in oral cancer. Cancer Lett 338(2):300\u2013316","journal-title":"Cancer Lett"},{"issue":"1","key":"4_CR239","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1600-0714.2012.01170.x","volume":"42","author":"AJ Dalley","year":"2013","unstructured":"Dalley AJ et al (2013) Organotypic culture of normal, dysplastic and squamous cell carcinoma-derived oral cell lines reveals loss of spatial regulation of CD44 and p75NTR in malignancy. J Oral Pathol Med 42(1):37\u201346","journal-title":"J Oral Pathol Med"},{"key":"4_CR240","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/2045-3701-4-69","volume":"4","author":"VR Zellmer","year":"2014","unstructured":"Zellmer VR, Zhang SY (2014) Evolving concepts of tumor heterogeneity. Cell Biosci 4:69","journal-title":"Cell Biosci"},{"key":"4_CR241","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ejca.2016.12.035","volume":"76","author":"JD Moy","year":"2017","unstructured":"Moy JD, Moskovitz JM, Ferris RL (2017) Biological mechanisms of immune escape and implications for immunotherapy in head and neck squamous cell carcinoma. Eur J Cancer 76:152\u2013166","journal-title":"Eur J Cancer"},{"key":"4_CR242","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.oraloncology.2016.05.008","volume":"58","author":"F Concha-Benavente","year":"2016","unstructured":"Concha-Benavente F et al (2016) Immunological and clinical significance of HLA class I antigen processing machinery component defects in malignant cells. Oral Oncol 58:52\u201358","journal-title":"Oral Oncol"},{"issue":"7","key":"4_CR243","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00262-011-1007-5","volume":"60","author":"TSD Malaspina","year":"2011","unstructured":"Malaspina TSD et al (2011) Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma. Cancer Immunol Immunother 60(7):965\u2013974","journal-title":"Cancer Immunol Immunother"},{"issue":"12","key":"4_CR244","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.oraloncology.2011.08.007","volume":"47","author":"YA Cho","year":"2011","unstructured":"Cho YA et al (2011) Relationship between the expressions of PD-L1 and tumor-infiltrating lymphocytes in oral squamous cell carcinoma. Oral Oncol 47(12):1148\u20131153","journal-title":"Oral Oncol"},{"issue":"5","key":"4_CR245","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.neo.2016.03.004","volume":"18","author":"KA Finkel","year":"2016","unstructured":"Finkel KA et al (2016) IL-6 inhibition with MEDI5117 decreases the fraction of head and neck cancer stem cells and prevents tumor recurrence. Neoplasia 18(5):273\u2013281","journal-title":"Neoplasia"},{"issue":"2","key":"4_CR246","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.yexcr.2019.03.013","volume":"378","author":"X Li","year":"2019","unstructured":"Li X et al (2019) CXCL12\/CXCR4 pathway orchestrates CSC-like properties by CAF recruited tumor associated macrophage in OSCC. Exp Cell Res 378(2):131\u2013138","journal-title":"Exp Cell Res"},{"issue":"1","key":"4_CR247","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188847","volume":"13","author":"EK Kim","year":"2018","unstructured":"Kim EK et al (2018) CXCL1 induces senescence of cancer-associated fibroblasts via autocrine loops in oral squamous cell carcinoma. PLoS One 13(1):e0188847","journal-title":"PLoS One"},{"issue":"8","key":"4_CR248","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/sj.bjc.6605891","volume":"103","author":"R Kesselring","year":"2010","unstructured":"Kesselring R et al (2010) Human Th17 cells can be induced through head and neck cancer and have a functional impact on HNSCC development. Br J Cancer 103(8):1245\u20131254","journal-title":"Br J Cancer"},{"key":"4_CR249","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.canep.2018.12.008","volume":"58","author":"S Mazumder","year":"2019","unstructured":"Mazumder S et al (2019) Liquid biopsy: miRNA as a potential biomarker in oral cancer. Cancer Epidemiol 58:137\u2013145","journal-title":"Cancer Epidemiol"},{"key":"4_CR250","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.oraloncology.2017.09.012","volume":"74","author":"P Economopoulou","year":"2017","unstructured":"Economopoulou P et al (2017) Liquid biopsy: an emerging prognostic and predictive tool in head and neck squamous cell carcinoma (HNSCC). Focus on circulating tumor cells (CTCs). Oral Oncol 74:83\u201389","journal-title":"Oral Oncol"},{"issue":"3","key":"4_CR251","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s10555-017-9685-x","volume":"36","author":"JA Bellairs","year":"2017","unstructured":"Bellairs JA, Hasina R, Agrawal N (2017) Tumor DNA: an emerging biomarker in head and neck cancer. Cancer Metastasis Rev 36(3):515\u2013523","journal-title":"Cancer Metastasis Rev"},{"key":"4_CR252","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.oraloncology.2017.10.007","volume":"75","author":"JH van Ginkel","year":"2017","unstructured":"van Ginkel JH et al (2017) Cell-free nucleic acids in body fluids as biomarkers for the prediction and early detection of recurrent head and neck cancer: A systematic review of the literature. Oral Oncol 75:8\u201315","journal-title":"Oral Oncol"},{"issue":"8","key":"4_CR253","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00262-011-1025-3","volume":"60","author":"JZ Niu","year":"2011","unstructured":"Niu JZ et al (2011) Foxp3 expression in melanoma cells as a possible mechanism of resistance to immune destruction. Cancer Immunol Immunother 60(8):1109\u20131118","journal-title":"Cancer Immunol Immunother"},{"issue":"7","key":"4_CR254","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.celrep.2015.01.035","volume":"10","author":"D Keskin","year":"2015","unstructured":"Keskin D et al (2015) Targeting vascular pericytes in hypoxic tumors increases lung metastasis via angiopoietin-2. Cell Rep 10(7):1066\u20131081","journal-title":"Cell Rep"},{"issue":"3","key":"4_CR255","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119348","volume":"10","author":"C Wang","year":"2015","unstructured":"Wang C et al (2015) Human adipocytes stimulate invasion of breast cancer MCF-7 cells by secreting IGFBP-2. PLoS One 10(3):e0119348","journal-title":"PLoS One"},{"issue":"11","key":"4_CR256","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/nm.2492","volume":"17","author":"KM Nieman","year":"2011","unstructured":"Nieman KM et al (2011) Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med 17(11):1498\u20131503","journal-title":"Nat Med"},{"issue":"10","key":"4_CR257","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141602","volume":"10","author":"A Yadav","year":"2015","unstructured":"Yadav A et al (2015) Tumor-associated endothelial cells promote tumor metastasis by chaperoning circulating tumor cells and protecting them from Anoikis. PLoS One 10(10):e0141602","journal-title":"PLoS One"},{"issue":"23","key":"4_CR258","doi-asserted-by":"publisher","first-page":"7593","DOI":"10.1158\/1078-0432.CCR-08-1164","volume":"14","author":"GE Ayala","year":"2008","unstructured":"Ayala GE et al (2008) Cancer-related axonogenesis and neurogenesis in prostate cancer. Clin Cancer Res 14(23):7593\u20137603","journal-title":"Clin Cancer Res"},{"key":"4_CR259","doi-asserted-by":"crossref","unstructured":"Fang JY et al (2014) Tumor bioengineering using a transglutaminase crosslinked hydrogel. PLoS One 9(8)","DOI":"10.1371\/journal.pone.0105616"},{"issue":"6142","key":"4_CR260","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.1236361","volume":"341","author":"C Magnon","year":"2013","unstructured":"Magnon C et al (2013) Autonomic nerve development contributes to prostate cancer progression. Science 341(6142):143","journal-title":"Science"},{"issue":"250","key":"4_CR261","doi-asserted-by":"publisher","first-page":"250ra115","DOI":"10.1126\/scitranslmed.3009569","volume":"6","author":"CM Zhao","year":"2014","unstructured":"Zhao CM et al (2014) Denervation suppresses gastric tumorigenesis. Sci Transl Med 6(250):250ra115","journal-title":"Sci Transl Med"},{"issue":"6","key":"4_CR262","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1001\/archotol.124.6.637","volume":"124","author":"JJ Fagan","year":"1998","unstructured":"Fagan JJ et al (1998) Perineural invasion in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 124(6):637\u2013640","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"6","key":"4_CR263","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1001\/archotol.124.6.637","volume":"124","author":"JJ Fagan","year":"1998","unstructured":"Fagan JJ et al (1998) Perineural invasion in squamous cell carcinoma of the head and neck. Archiv Otolaryngol Head & Neck Surg 124(6):637\u2013640","journal-title":"Archiv Otolaryngol Head & Neck Surg"},{"issue":"8","key":"4_CR264","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1097\/PAS.0b013e318285f684","volume":"37","author":"S-K Tai","year":"2013","unstructured":"Tai S-K et al (2013) Perineural invasion in T1 oral squamous cell carcinoma indicates the need for aggressive elective neck dissection. Am J Surg Pathol 37(8):1164\u20131172","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"4_CR265","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/hed.23293","volume":"36","author":"P Sinha","year":"2014","unstructured":"Sinha P et al (2014) Transoral laser microsurgery for oral squamous cell carcinoma: oncologic outcomes and prognostic factors. Head & Neck 36(3):340\u2013351","journal-title":"Head & Neck"},{"issue":"6","key":"4_CR266","first-page":"1747","volume":"271","author":"FR Pinto","year":"2014","unstructured":"Pinto FR et al (2014) Tumor thickness as an independent risk factor of early recurrence in oral cavity squamous cell carcinoma. Eur Arch Otorhinolaryngol 271(6):1747\u20131754","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"4_CR267","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.oraloncology.2018.09.005","volume":"86","author":"Z Saidak","year":"2018","unstructured":"Saidak Z et al (2018) A gene expression profile associated with perineural invasion identifies a subset of HNSCC at risk of post-surgical recurrence. Oral Oncol 86:53\u201360","journal-title":"Oral Oncol"},{"key":"4_CR268","doi-asserted-by":"crossref","unstructured":"Prazeres P et al (2020) Ablation of sensory nerves favours melanoma progression. J Cell Mol Med","DOI":"10.1111\/jcmm.15381"}],"container-title":["Advances in Experimental Medicine and Biology","Tumor Microenvironments in Organs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-59038-3_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T22:38:17Z","timestamp":1725316697000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-59038-3_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030590376","9783030590383"],"references-count":268,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-59038-3_4","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"30 June 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}